The taintedblood Timeline - what really happened...
"To no one will we sell, to no one deny or delay, right or justice."
Magna Carta - 15th June, 1215
No of entries selected: 4 of 711
Behringwerke AG (German blood product manufacturer)
A pasteurization procedure is developed and licensed in Germany by blood product manufacturer Behringwerke AG. It involves heating factor concentrates at 60°C for ten hours. An article demonstrating the efficacy of the pasteurization process is published the same year.
Note: Other manufacturers are reluctant to adopt this technique over concerns regarding:
- 50-90% loss of yield,
- factor supply could be in jeopardy
- pasteurized factor will cost ten times more
- concerns over the effectiveness of inactivating non-A non-B hepatitis
- patients might develop inhibitors.
Krever Commission Report (1997), Vol 3, Part IV, Chap. 27, page 754.
Additional Source: NEJM, Vol 316, No 15 pps 918 - 922.Type:
Pasteurisation procedure licensed Location:
Germany / USA Find related entries
Cutter - License / Pasteurization Process
Cutter receives US license to distribute factor concentrates subjected to a liquid pasteurisation process involving heating at 60°C for ten hours.
Krever Commission Report (1997), Vol 3, Part IV, Chap. 27, page 755.Type:
US License Pasteurization Location:
USA Find related entries
Bayer - Secures Patent for Pasteurisation Process
Bayer publishes a patented method for the pasteurization of Factor VIII.
Miss Cunningham / BTSB - HT3
It is now known (in 1987) that dry heating is ineffective in preventing Non-A Non-B Hepatitis. In a scientific meeting, Miss Cunningham, discusses various methods of heat treatment, and notes that the British protocol of pasteurisation of 80° Centigrade for 72 hours is effective against transmission of Non-A, Non-B Hepatitis and AIDS.
Timeline Copyright ©2006 Andrew March & Haydn Lewis
All rights reserved